Clinical trial
Establishing Novel Functional Biomarkers for Creatine Deficiency Syndromes
NCT06292884 is registered in ClinicalTrials.gov with IRCCS Fondazione Stella Maris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Establishing Novel Functional Biomarkers for Creatine Deficiency Syndromes
- Lead sponsor
- IRCCS Fondazione Stella Maris
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 6, 2023
- Completion date
- December 15, 2025
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
creatine deficiency syndrome due to gamt deficiency, creatine deficiency, x-linked